Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Harsha R. Mittakanti is a leading figure in urologic oncology, with a focused expertise in minimally invasive surgical techniques for genitourinary cancers. His primary research centers on advancing robotic-assisted surgery, particularly for renal and testicular malignancies. Dr. Mittakanti’s most impactful contribution is a landmark matched-paired analysis comparing transperitoneal versus retroperitoneal robotic partial nephrectomy, which has garnered 68 citations and provides critical guidance for surgical approach selection in kidney cancer. He is also a pioneer in the application of robot-assisted laparoscopic retroperitoneal lymph node dissection (R-RPLND) for testicular cancer, authoring key studies (32 and 15 citations) that demonstrate this technique as a viable, less morbid alternative to the traditional open approach for both primary and post-chemotherapy settings. His work has been instrumental in establishing R-RPLND as a standard option in the treatment of stage I non-seminomatous germ cell tumors. Through these contributions, Dr. Mittakanti has significantly shaped the modern, minimally invasive landscape of urologic oncology, improving patient recovery and outcomes.